Study of Genetic Anomalies of Complement Related Proteins in Patients With IgA Glomerulonephritis
|ClinicalTrials.gov Identifier: NCT00004305|
Recruitment Status : Completed
First Posted : October 19, 1999
Last Update Posted : June 24, 2005
OBJECTIVES: I. Determine whether allelic differences associated with the fourth component of complement, type-1 complement receptor expressed on erythrocytes, and Fc receptor FcgRIII contribute to the pathogenesis of IgA glomerulonephritis (IgA-N).
II. Compare genetic anomalies of these key components in immune complex processing and clearance between juvenile vs adult onset IgA-N vs normal controls.
|Condition or disease|
Participants undergo qualitative genetic analysis of complement-related proteins. Studies include: genomic re-arrangement of 4-gene unit, C4 DNA sequence and RNA expression, type-1 complement receptor DNA sequence, Fc-gamma receptor IIIA isoform analysis, classical and alternative complement activation pathway assays, plasma C4 and C4d protein levels, and immunoglobulin patterns in glomerular deposits.
|Study Type :||Observational|
|Enrollment :||105 participants|
|Study Start Date :||January 1998|
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00004305
|United States, Ohio|
|Ohio State University|
|Columbus, Ohio, United States|
|Study Chair:||Lee A. Hebert||Ohio State University|